Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

The number needed to treat: a clinically useful nomogram in its proper context.

Chatellier G, Zapletal E, Lemaitre D, Menard J, Degoulet P.

BMJ. 1996 Feb 17;312(7028):426-9. Erratum in: BMJ 1996 Mar 2;312(7030):563.

2.

The number needed to treat: a clinically useful measure of treatment effect.

Cook RJ, Sackett DL.

BMJ. 1995 Feb 18;310(6977):452-4. Erratum in: BMJ 1995 Apr 22;310(6986):1056.

3.

Number needed to treat (or harm).

Tramèr MR, Walder B.

World J Surg. 2005 May;29(5):576-81.

PMID:
15827840
4.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

5.
6.

Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.

Hutton JL.

Br J Haematol. 2009 Jun;146(1):27-30. doi: 10.1111/j.1365-2141.2009.07707.x. Epub 2009 Apr 27. Review.

PMID:
19438480
7.
8.

Number needed to treat: a descriptor for weighing therapeutic options.

Wen L, Badgett R, Cornell J.

Am J Health Syst Pharm. 2005 Oct 1;62(19):2031-6.

PMID:
16174840
9.

The 'number need to treat': does it help clinical decision making?

Ebrahim S, Smith GD.

J Hum Hypertens. 1999 Nov;13(11):721-4. Review.

PMID:
10578213
10.

Seizure prophylaxis in hypertensive pregnancies: a framework for making clinical decisions.

Khan KS, Chien PF.

Br J Obstet Gynaecol. 1997 Oct;104(10):1173-9. Review.

PMID:
9332996
11.

Evaluating analgesia: the challenges.

McQuay HJ, Edwards JE, Moore RA.

Am J Ther. 2002 May-Jun;9(3):179-87. Review.

PMID:
11941377
12.

Disease-modifying therapy in multiple sclerosis: update and clinical implications.

Goodin DS.

Neurology. 2008 Dec 9;71(24 Suppl 3):S8-13. doi: 10.1212/WNL.0b013e31818f3d8b.

PMID:
19064873
13.

What have we learned from the current trials?

Abbott KC, Bakris GL.

Med Clin North Am. 2004 Jan;88(1):189-207. Review.

PMID:
14871059
14.

[Using "number needed to treat" to interpret treatment effect].

Ke DS.

Acta Neurol Taiwan. 2006 Jun;15(2):120-6. Chinese.

PMID:
16871900
15.
16.

[Controlled randomized clinical trials].

Jaillon P.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):739-56; discussion 756-8. French.

PMID:
18225427
17.

Interpretation of absolute measures of disease risk in comparative research.

Replogle WH, Johnson WD.

Fam Med. 2007 Jun;39(6):432-5.

18.

The 'number needed to treat' and the 'adjusted NNT' in health care decision-making.

Dowie J.

J Health Serv Res Policy. 1998 Jan;3(1):44-9.

PMID:
10180389
19.
20.

Using the number needed to treat in clinical practice.

Weeks DL, Noteboom JT.

Arch Phys Med Rehabil. 2004 Oct;85(10):1729-31.

PMID:
15468039
Items per page

Supplemental Content

Write to the Help Desk